Suppr超能文献

老年急性心肌梗死患者的衰弱与经皮冠状动脉介入治疗结局。

Frailty Among Older Adults With Acute Myocardial Infarction and Outcomes From Percutaneous Coronary Interventions.

机构信息

Inova Center of Outcomes Research Inova Heart and Vascular Institute Falls Church VA.

Division of Cardiology Johns Hopkins University Baltimore MD.

出版信息

J Am Heart Assoc. 2019 Sep 3;8(17):e013686. doi: 10.1161/JAHA.119.013686. Epub 2019 Aug 31.

Abstract

Background Frailty is a predictor of adverse outcomes after acute myocardial infarction (AMI). Methods and Results We estimated the prevalence of frailty among adults age ≥75 years admitted with AMI and examined the relationship between frailty, interventions, and mortality. We used the Premier Healthcare Database to identify older adults with primary diagnoses of AMI. We classified individuals as frail or not using the validated Claims-based Frailty Index. We described patients' characteristics and receipt of percutaneous coronary intervention stratified by frailty status. The primary outcome was hospital mortality. From 2000 to 2016, we identified 469 390 encounters for older patients admitted with AMI. The median age was 82 years, 53% were women, and 75% were white. The prevalence of frailty was 19%. Frail patients were less likely to receive percutaneous coronary intervention than nonfrail (15% versus 33%, P<0.001) and much less likely to receive coronary artery bypass surgery (1% versus 9%, P<0.001). There were far fewer interventions in individuals over age 85 years. Frailty was associated with higher mortality during AMI admission (unadjusted odds ratio [OR] 1.43, CI 1.39-1.46). While there was a differential benefit of the interventions because of frailty, frail patients had reduced hospital mortality with percutaneous coronary intervention (frail: OR 0.59, CI 0.55-0.63; nonfrail: OR 0.49, CI 0.47-0.50, P for interaction <0.001) and with coronary artery bypass surgery (frail: OR 0.77, CI 0.65-0.93; nonfrail: OR 0.74, CI 0.71-0.77, P for interaction <0.001) relative to no intervention. Conclusions In the United States, frailty is common among older patients admitted with AMI. While these vulnerable patients are at an increased risk for mortality, judicial use of revascularization with percutaneous coronary intervention in frail older patients still confers immediate survival benefit.

摘要

背景

衰弱是急性心肌梗死(AMI)后不良结局的预测因素。

方法和结果

我们估计了年龄≥75 岁因 AMI 入院的成年人中衰弱的患病率,并检查了衰弱、干预措施和死亡率之间的关系。我们使用 Premier Healthcare Database 来确定有 AMI 主要诊断的老年人。我们使用经过验证的基于索赔的衰弱指数将个体分类为衰弱或非衰弱。我们描述了按衰弱状态分层的患者特征和接受经皮冠状动脉介入治疗的情况。主要结局是医院死亡率。2000 年至 2016 年,我们确定了 469390 名因 AMI 入院的老年患者的就诊记录。中位年龄为 82 岁,53%为女性,75%为白人。衰弱的患病率为 19%。与非衰弱患者相比,衰弱患者接受经皮冠状动脉介入治疗的可能性较小(15%对 33%,P<0.001),接受冠状动脉旁路移植术的可能性小得多(1%对 9%,P<0.001)。85 岁以上的个体接受的干预措施要少得多。衰弱与 AMI 住院期间死亡率升高有关(未调整优势比[OR]1.43,95%CI 1.39-1.46)。尽管由于衰弱存在干预的差异获益,但与不进行干预相比,经皮冠状动脉介入治疗(衰弱:OR 0.59,95%CI 0.55-0.63;非衰弱:OR 0.49,95%CI 0.47-0.50,P 交互作用<0.001)和冠状动脉旁路移植术(衰弱:OR 0.77,95%CI 0.65-0.93;非衰弱:OR 0.74,95%CI 0.71-0.77,P 交互作用<0.001)可降低衰弱患者的住院死亡率。

结论

在美国,因 AMI 入院的老年患者中衰弱很常见。尽管这些脆弱的患者死亡风险增加,但在衰弱的老年患者中合理使用经皮冠状动脉介入治疗血运重建仍然可以立即带来生存获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fafa/6755849/18eb45c8fb22/JAH3-8-e013686-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验